Rui Zhang
Soochow University (Suzhou)
Internal medicinePopulationAngiotensin IIStrokeMedicine
What is this?
Publications 3
#1Chenhuan Zhang (Soochow University (Suzhou))
#2Sifan Qian (Soochow University (Suzhou))H-Index: 1
Last. Tan Xu (Soochow University (Suzhou))H-Index: 14
view all 15 authors...
Abstract Background and aims Endostatin is implicated in the atherosclerosis process and serves as a promising cardiovascular biomarker, while its clinical significance in ischemic stroke patients remains unclear. We aimed to examine the association between endostatin and mortality and disability after ischemic stroke. Methods A total of 3463 acute ischemic stroke patients with measured plasma endostatin from the China Antihypertensive Trial in Acute Ischemic Stroke were included in this study. ...
1 CitationsSource
#1Yiting Zhou (Soochow University (Suzhou))H-Index: 1
#2Rui Zhang (Soochow University (Suzhou))
Last. Yonghong Zhang (Soochow University (Suzhou))H-Index: 15
view all 9 authors...
AbstractObjective: To investigate the coexistence effect of hypertension and angiotensin II on the risk of coronary heart disease based on a prospective study in an Inner Mongolian population of Ch...
#1Rui Zhang (Soochow University (Suzhou))
#2Chongke Zhong (Soochow University (Suzhou))H-Index: 6
Last. Jiang He (Tulane University)H-Index: 103
view all 17 authors...
Importance Clinical trials have generally shown a neutral effect of early blood pressure (BP) decreases on clinical outcomes after acute ischemic stroke. Whether the effect of early antihypertensive therapy differs for patients with ischemic stroke with or without prior hypertension is unclear. Objective To investigate the association between immediate antihypertensive treatment and patient outcomes according to the presence or absence of hypertension before stroke onset. Design, Setting, and Pa...